Annual EBIT
-$15.77 M
-$1.16 M-7.93%
December 31, 2023
Summary
- As of March 10, 2025, ENTO annual earnings before interest & taxes is -$15.77 million, with the most recent change of -$1.16 million (-7.93%) on December 31, 2023.
- During the last 3 years, ENTO annual EBIT has risen by +$11.06 million (+41.22%).
- ENTO annual EBIT is now -263.20% below its all-time high of -$4.34 million, reached on December 1, 2015.
Performance
ENTO EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$1.89 M
+$1.53 M+44.76%
September 1, 2024
Summary
- As of March 10, 2025, ENTO quarterly earnings before interest & taxes is -$1.89 million, with the most recent change of +$1.53 million (+44.76%) on September 1, 2024.
- Over the past year, ENTO quarterly EBIT has stayed the same.
- ENTO quarterly EBIT is now -143.09% below its all-time high of $4.39 million, reached on September 1, 2022.
Performance
ENTO Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$18.64 M
+$1.54 M+7.63%
September 1, 2024
Summary
- As of March 10, 2025, ENTO TTM earnings before interest & taxes is -$18.64 million, with the most recent change of +$1.54 million (+7.63%) on September 1, 2024.
- Over the past year, ENTO TTM EBIT has stayed the same.
- ENTO TTM EBIT is now -1681.01% below its all-time high of -$1.05 million, reached on March 1, 2015.
Performance
ENTO TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ENTO EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -7.9% | 0.0% | 0.0% |
| 3 y3 years | +41.2% | 0.0% | 0.0% |
| 5 y5 years | -17.4% | 0.0% | 0.0% |
ENTO EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -7.9% | +73.0% | -143.1% | +80.3% | -137.9% | +69.2% |
| 5 y | 5-year | -7.9% | +73.0% | -143.1% | +93.8% | -137.9% | +71.2% |
| alltime | all time | -263.2% | +73.0% | -143.1% | +93.8% | -1681.0% | +71.2% |
Entero Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.89 M(-44.8%) | -$18.64 M(-7.6%) |
| Jun 2024 | - | -$3.43 M(-62.9%) | -$20.18 M(-3.6%) |
| Mar 2024 | - | -$9.23 M(+125.3%) | -$20.94 M(+32.7%) |
| Dec 2023 | -$15.77 M(+7.9%) | -$4.10 M(+19.3%) | -$15.77 M(+0.7%) |
| Sep 2023 | - | -$3.43 M(-18.0%) | -$15.66 M(+99.9%) |
| Jun 2023 | - | -$4.18 M(+3.0%) | -$7.83 M(-13.5%) |
| Mar 2023 | - | -$4.06 M(+2.1%) | -$9.05 M(-38.0%) |
| Dec 2022 | -$14.61 M(-75.0%) | - | - |
| Dec 2022 | - | -$3.98 M(-190.6%) | -$14.61 M(-33.0%) |
| Sep 2022 | - | $4.39 M(-181.3%) | -$21.80 M(-61.5%) |
| Jun 2022 | - | -$5.40 M(-43.8%) | -$56.60 M(-6.4%) |
| Mar 2022 | - | -$9.62 M(-13.9%) | -$60.47 M(+3.3%) |
| Dec 2021 | -$58.53 M(+118.1%) | -$11.17 M(-63.3%) | -$58.53 M(-9.6%) |
| Sep 2021 | - | -$30.40 M(+227.7%) | -$64.75 M(+68.3%) |
| Jun 2021 | - | -$9.28 M(+20.8%) | -$38.47 M(+21.8%) |
| Mar 2021 | - | -$7.68 M(-55.9%) | -$31.58 M(+17.7%) |
| Dec 2020 | -$26.83 M(+82.0%) | -$17.40 M(+323.3%) | -$26.83 M(+154.1%) |
| Sep 2020 | - | -$4.11 M(+71.7%) | -$10.56 M(+0.3%) |
| Jun 2020 | - | -$2.39 M(-18.3%) | -$10.53 M(-19.4%) |
| Mar 2020 | - | -$2.93 M(+160.1%) | -$13.07 M(-11.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$14.74 M(+9.8%) | -$1.13 M(-72.4%) | -$14.74 M(-16.4%) |
| Sep 2019 | - | -$4.08 M(-17.2%) | -$17.64 M(+9.4%) |
| Jun 2019 | - | -$4.93 M(+7.1%) | -$16.12 M(+11.6%) |
| Mar 2019 | - | -$4.60 M(+14.6%) | -$14.45 M(+7.6%) |
| Dec 2018 | -$13.43 M(+31.4%) | -$4.02 M(+56.6%) | -$13.43 M(+14.6%) |
| Sep 2018 | - | -$2.57 M(-21.4%) | -$11.72 M(-1.3%) |
| Jun 2018 | - | -$3.26 M(-9.0%) | -$11.88 M(+8.0%) |
| Mar 2018 | - | -$3.58 M(+55.7%) | -$11.00 M(+7.6%) |
| Dec 2017 | -$10.22 M(+18.1%) | -$2.30 M(-15.6%) | -$10.22 M(+8.3%) |
| Sep 2017 | - | -$2.73 M(+14.3%) | -$9.44 M(+2.8%) |
| Jun 2017 | - | -$2.38 M(-15.1%) | -$9.19 M(-9.8%) |
| Mar 2017 | - | -$2.81 M(+84.7%) | -$10.19 M(+17.7%) |
| Dec 2016 | -$8.65 M(+99.3%) | -$1.52 M(-38.5%) | -$8.65 M(+21.0%) |
| Sep 2016 | - | -$2.47 M(-26.9%) | -$7.15 M(+18.6%) |
| Jun 2016 | - | -$3.38 M(+164.8%) | -$6.03 M(+31.9%) |
| Mar 2016 | - | -$1.28 M(+5898.1%) | -$4.57 M(+5.3%) |
| Dec 2015 | -$4.34 M | -$21.30 K(-98.4%) | -$4.34 M(+0.5%) |
| Sep 2015 | - | -$1.35 M(-29.6%) | -$4.32 M(+45.6%) |
| Jun 2015 | - | -$1.92 M(+83.6%) | -$2.97 M(+183.6%) |
| Mar 2015 | - | -$1.05 M | -$1.05 M |
FAQ
- What is Entero Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Entero Therapeutics?
- What is Entero Therapeutics annual EBIT year-on-year change?
- What is Entero Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Entero Therapeutics?
- What is Entero Therapeutics quarterly EBIT year-on-year change?
- What is Entero Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Entero Therapeutics?
- What is Entero Therapeutics TTM EBIT year-on-year change?
What is Entero Therapeutics annual earnings before interest & taxes?
The current annual EBIT of ENTO is -$15.77 M
What is the all time high annual EBIT for Entero Therapeutics?
Entero Therapeutics all-time high annual earnings before interest & taxes is -$4.34 M
What is Entero Therapeutics annual EBIT year-on-year change?
Over the past year, ENTO annual earnings before interest & taxes has changed by -$1.16 M (-7.93%)
What is Entero Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of ENTO is -$1.89 M
What is the all time high quarterly EBIT for Entero Therapeutics?
Entero Therapeutics all-time high quarterly earnings before interest & taxes is $4.39 M
What is Entero Therapeutics quarterly EBIT year-on-year change?
Over the past year, ENTO quarterly earnings before interest & taxes has changed by $0.00 (0.00%)
What is Entero Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of ENTO is -$18.64 M
What is the all time high TTM EBIT for Entero Therapeutics?
Entero Therapeutics all-time high TTM earnings before interest & taxes is -$1.05 M
What is Entero Therapeutics TTM EBIT year-on-year change?
Over the past year, ENTO TTM earnings before interest & taxes has changed by $0.00 (0.00%)